Skin conditions (dermatitis, eczema, psoriasis) decisions — 2025

The Board denied the veteran's appeal for earlier effective dates for service connection of multiple conditions, including multiple myeloma, schizotypal personality disorder with mild neurocognitive disorder, fibromyalgia, vitamin D deficiency, migraine headaches, and others.

The Board denied the veteran's claims for increased ratings and granted a rating of 20 percent, but no higher, for right knee meniscus tear, post arthroscopic surgery.

The Veteran was granted a total disability rating based on individual unemployability (TDIU) for the period beginning October 6, 2014.

The Board denied a compensable rating for pseudofolliculitis barbae as the Veteran's condition involved less than 5 percent of the total or exposed body area and did not require intermittent systemic therapy.

The Board granted service connection for posttraumatic stress disorder (PTSD) and secondary service connections for insomnia / sleep problems, headache disorder, and RIGHT knee osteoarthritis. Service connection for bilateral hearing loss disability and pseudofolliculitis barbae of the skin was denied.

The Board denied a compensable evaluation for psoriasis and bilateral inguinal hernia repair, but granted a 10 percent evaluation for right ear hearing loss effective July 19, 2021.

The Board denied service connection for GERD, hemorrhoids, left foot pain (also claimed as pes planus and plantar fasciitis), and pseudofolliculitis barbae due to a lack of evidence showing current disabilities or that the conditions were incurred in or aggravated by active service.

The Board granted service connection for a back disability and a left shoulder disability, but denied increased ratings for PTSD and TMD, as well as service connections for chronic sinusitis, respiratory insufficiency, dyspnea, CFS, fibromyalgia, dermatitis, functional abdominal pain syndrome, bloating, hypogonadism, hypothyroidism, IBS, and sleep apnea.

The Board denied service connection for several conditions, granted an initial rating of 10 percent for chronic constipation, and granted higher ratings of 30 percent for bilateral peripheral vestibular disorder and 20 percent for bilateral dry eye.

The Board remands the issue of entitlement to service connection for pseudofolliculitis barbae due to a predecisional duty to assist error in the previous VA opinion.

The Veteran's service-connected anxiety alone has precluded him from securing or following substantially gainful employment, and he meets the criteria for a TDIU. Additionally, he is entitled to Special Monthly Compensation (SMC) due to his combined disability rating.

The Board denied the veteran's claims for service connection for acne, hemorrhoids, a lung condition, migraine headaches, and scars from acne due to insufficient evidence of current disabilities or a nexus between these conditions and his military service.

The Board granted service connection for tinea pedis and remanded claims for increased rating and additional service connection.

The Board remands the claims for service connection due to a need for additional development, including verification of toxic exposure risk activities and obtaining medical opinions.

The Board granted an initial rating of 30 percent for eczema, but denied a compensable rating for bilateral tinea pedis.

The Board remands the claims for service connection for various disabilities, including respiratory issues, sleep apnea, skin conditions, and shaking, due to deficiencies in the medical nexus opinions.

The Board remands the claims for service connection for diabetes mellitus, prostate cancer, a skin condition, and a bilateral foot condition due to insufficient evidence in the file.

The Board denied increased ratings for various disabilities and granted service connection for residuals of frostbite in the hands and sinusitis, while remanding several issues for further consideration.

The Veteran withdrew the appeal for all service connection and increased rating claims, effective March 14, 2025.

The Board denied increased ratings for seborrheic dermatitis, diabetes mellitus II, left and right upper extremity peripheral neuropathy, and right lower extremity peripheral neuropathy. However, it granted an initial 40 percent rating for both the right and left lower extremity peripheral neuropathy, as well as a 10 percent rating for hypertension.